Skip to main content

Clinical Trial Results


Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss: XIENCE 90/28: Assessment of Three-Month and One-Month DAPT After Everolimus-Eluting Stents in High-Bleeding Risk Patients

Loader Loading…
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab


Disclosures: TBD